Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The action of HCS and
HCG
on cell-mediated immunity has been investigated. Full-thickness skin homografts were performed in 40 whole adult female Wistar rats.
Brown
rats of the A X C strain were selected as donors. The animals were divided into four groups injected with HCS,
HCG
, HCS +
HCG
, and saline. The graft rejection time and the wet and dry weight of thymus and spleen were evaluated. No hormonal treatment showed any effect on skin graft survival. Thymus weight, both wet and dry, decreased significantly by treatment with HCP or HCS +
HCG
. No modification was observed in spleen weight. These results do not agree with the theory that HCS and
HCG
modify immunological competence of maternal lymphocytes and thus may contribute to prevent rejection of the fetus.
...
PMID:Effects of human chorionic somatomammotropin and human chorionic gonadotropin on skin homografts in rats. 80 Mar 86
Tatton-
Brown
-Rahman syndrome is a new overgrowth syndrome due to DNMT3A (DNA cytosine 5 methyltransferase 3A) mutations. Mutation carriers show a distinctive facial appearance, intellectual disability, and increased height. We report a patient with overgrowth who showed submicroscopic deletion of chromosome 2p23 including DNMT3A. The deletion was detected by array-
CGH
. He showed moderate ID and distinctive facial gestalt. His clinical features were consistent with those of Tatton-
Brown
-Rahman syndrome. We suggest that 2p23 microdeletion including DNMT3A may cause similar symptoms in patients with DNMT3A mutations and should be considered in patients with overgrowth.
...
PMID:Tatton-Brown-Rahman syndrome due to 2p23 microdeletion. 2686 22